{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:38:17Z","timestamp":1792165097523,"version":"4.4.0"},"reference-count":33,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Prader-Willi syndrome (PWS) is a rare genetic disorder characterized by endocrine and neuropsychiatric problems including hyperphagia, anxiousness, and distress. Intranasal carbetocin, an oxytocin analog, was investigated as a selective oxytocin replacement therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To evaluate safety and efficacy of intranasal carbetocin in PWS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Randomized, double-blind, placebo-controlled phase 3 trial with long-term follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Twenty-four ambulatory clinics at academic medical centers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>A total of 130 participants with PWS aged 7 to 18 years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Interventions<\/jats:title>\n                  <jats:p>Participants were randomized to 9.6 mg\/dose carbetocin, 3.2 mg\/dose carbetocin, or placebo 3 times daily during an 8-week placebo-controlled period (PCP). During a subsequent 56-week long-term follow-up period, placebo participants were randomly assigned to 9.6 mg or 3.2 mg carbetocin, with carbetocin participants continuing at their previous dose.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome measures<\/jats:title>\n                  <jats:p>Primary endpoints assessed change in hyperphagia (Hyperphagia Questionnaire for Clinical Trials [HQ-CT]) and obsessive-compulsive symptoms (Children's Yale-Brown Obsessive-Compulsive Scale [CY-BOCS]) during the PCP for 9.6 mg vs placebo, and the first secondary endpoints assessed these same outcomes for 3.2 mg vs placebo. Additional secondary endpoints included assessments of anxiousness and distress behaviors (PWS Anxiousness and Distress Behaviors Questionnaire [PADQ]) and clinical global impression of change (CGI-C).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Because of onset of the COVID-19 pandemic, enrollment was stopped prematurely. The primary endpoints showed numeric improvements in both HQ-CT and CY-BOCS which were not statistically significant; however, the 3.2-mg arm showed nominally significant improvements in HQ-CT, PADQ, and CGI-C scores vs placebo. Improvements were sustained in the long-term follow-up period. The most common adverse event during the PCP was mild to moderate flushing.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Carbetocin was well tolerated, and the 3.2-mg dose was associated with clinically meaningful improvements in hyperphagia and anxiousness and distress behaviors in participants with PWS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Trials Registration Number<\/jats:title>\n                  <jats:p>NCT03649477<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgad015","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T19:43:26Z","timestamp":1673552606000},"page":"1696-1708","source":"Crossref","is-referenced-by-count":52,"title":["Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial"],"prefix":"10.1210","volume":"108","author":[{"given":"Elizabeth","family":"Roof","sequence":"first","affiliation":[{"name":"Vanderbilt University , Nashville, TN 37240 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6434-2745","authenticated-orcid":false,"given":"Cheri L","family":"Deal","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Centre de Recherche , Montr\u00e9al, Qu\u00e9bec H3T 1C5 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5719-1520","authenticated-orcid":false,"given":"Shawn E","family":"McCandless","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Genetics and Metabolism, University of Colorado School of Medicine and Children's Hospital Colorado , Aurora, CO 80309 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0041-0670","authenticated-orcid":false,"given":"Ronald L","family":"Cowan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, The University of Tennessee Health Science Center College of Medicine , Memphis, TN 37996 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Florida College of Medicine , Gainesville, FL 32611 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill K","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, The Hospital for Sick Children , Toronto M5G 1X8 , Canada"},{"name":"Department of Pediatrics, University of Toronto , Toronto M5G 1X8 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8439-657X","authenticated-orcid":false,"given":"Elizabeth R","family":"Roeder","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine , San Antonio, TX 78207 , USA"},{"name":"Department of Molecular and Human Genetics, Baylor College of Medicine , Houston, TX 77030 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1143-4459","authenticated-orcid":false,"given":"Shana E","family":"McCormack","sequence":"additional","affiliation":[{"name":"Neuroendocrine Center, The Children's Hospital of Philadelphia Division of Endocrinology and Diabetes , Philadelphia, PA 19104 , USA"},{"name":"Department of Pediatrics, University of Pennsylvania Perelman School of Medicine , Philadelphia, PA 19104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6312-5677","authenticated-orcid":false,"given":"Tamanna R","family":"Roshan Lal","sequence":"additional","affiliation":[{"name":"Genetics and Metabolism, Children's National Hospital , Washington, DC 20010 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4316-6815","authenticated-orcid":false,"given":"Hussein D","family":"Abdul-Latif","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology and Diabetes, Children's of Alabama , Birmingham, AL 35233 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6256-4982","authenticated-orcid":false,"given":"Andrea M","family":"Haqq","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Alberta , Edmonton, Alberta T6G 2R3 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1443-577X","authenticated-orcid":false,"given":"Kathryn S","family":"Obrynba","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, Nationwide Children's Hospital , Columbus, OH 43205 , USA"},{"name":"Department of Pediatrics, The Ohio State University , Columbus, OH 43205 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2468-7137","authenticated-orcid":false,"given":"Laura C","family":"Torchen","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Ann and Robert H. Lurie Children's Hospital of Chicago, Feinberg School of Medicine, Northwestern University , Chicago, IL 60208 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3790-6255","authenticated-orcid":false,"given":"Alaina P","family":"Vidmar","sequence":"additional","affiliation":[{"name":"Diabetes & Obesity Program, Center for Endocrinology, Diabetes and Metabolism, Children's Hospital Los Angeles Department of Pediatrics , Los Angeles, CA 90027 , USA"},{"name":"Keck School of Medicine of USC , Los Angeles, CA 90033 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5364-3366","authenticated-orcid":false,"given":"David H","family":"Viskochil","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Medical Genetics, The University of Utah School of Medicine , Salt Lake City, UT 84112 , USA"},{"name":"Shriners Hospital for Children , Salt Lake City, UT 84112 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5167-2064","authenticated-orcid":false,"given":"Jean-Pierre","family":"Chanoine","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Endocrinology and Diabetes Unit, The University of British Columbia , Vancouver V6H 3V4 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol K L","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Endocrinology and Diabetes Unit, The University of British Columbia , Vancouver V6H 3V4 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9908-9409","authenticated-orcid":false,"given":"Melinda J","family":"Pierce","sequence":"additional","affiliation":[{"name":"Diabetes & Endocrinology, Children's Minnesota\u2014St Paul , St Paul, MN 55404 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2167-7806","authenticated-orcid":false,"given":"Laurel L","family":"Williams","sequence":"additional","affiliation":[{"name":"Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine , Houston, TX 77030 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4833-3747","authenticated-orcid":false,"given":"Lynne M","family":"Bird","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California San Diego , San Diego, CA 92037 , USA"},{"name":"Rady Children's Hospital , San Diego, CA 92123 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2911-0524","authenticated-orcid":false,"given":"Merlin G","family":"Butler","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Behavioral Sciences, University of Kansas Medical Center , Kansas City, KS 66160 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4449-6568","authenticated-orcid":false,"given":"Diane E","family":"Jensen","sequence":"additional","affiliation":[{"name":"Children's Health Queensland Hospital and Health Services , South Brisbane, Queensland 4101 , Australia"},{"name":"Centre for Children's Health Research, University of Queensland , Brisbane, Queensland 4101 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E","family":"Myers","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Saint Louis University School of Medicine, Cardinal Glennon Children's Hospital , Saint Louis, MO 63104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver J","family":"Oatman","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, Phoenix Children's Hospital , Phoenix, AZ 85016 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charumathi","family":"Baskaran","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Boston Children's Hospital , Boston, MA 02115 , USA"},{"name":"Department of Pediatrics, Harvard Medical School , Boston, MA 02115 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4454-423X","authenticated-orcid":false,"given":"Laura J","family":"Chalmers","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The University of Oklahoma School of Community Medicine , Tulsa, OK 73117 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7720-9249","authenticated-orcid":false,"given":"Cary","family":"Fu","sequence":"additional","affiliation":[{"name":"Vanderbilt University , Nashville, TN 37240 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1258-7665","authenticated-orcid":false,"given":"Nathalie","family":"Alos","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Centre de Recherche , Montr\u00e9al, Qu\u00e9bec H3T 1C5 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D","family":"McLean","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine , San Antonio, TX 78207 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Shah","sequence":"additional","affiliation":[{"name":"Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine , Houston, TX 77030 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Y","family":"Whitman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Saint Louis University School of Medicine, Cardinal Glennon Children's Hospital , Saint Louis, MO 63104 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1338-2370","authenticated-orcid":false,"given":"Brent A","family":"Blumenstein","sequence":"additional","affiliation":[{"name":"Trial Architecture Consulting , Chevy Chase, MD 20814 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah F","family":"Leonard","sequence":"additional","affiliation":[{"name":"Levo Therapeutics, Inc. , Skokie, IL 60077 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica P","family":"Ernest","sequence":"additional","affiliation":[{"name":"Levo Therapeutics, Inc. , Skokie, IL 60077 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W","family":"Cormier","sequence":"additional","affiliation":[{"name":"Levo Therapeutics, Inc. , Skokie, IL 60077 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara P","family":"Cotter","sequence":"additional","affiliation":[{"name":"Levo Therapeutics, Inc. , Skokie, IL 60077 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5831-9642","authenticated-orcid":false,"given":"Davis C","family":"Ryman","sequence":"additional","affiliation":[{"name":"Levo Therapeutics, Inc. , Skokie, IL 60077 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"issue":"1","key":"2023061601034999600_dgad015-B1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader-Willi syndrome","volume":"14","author":"Cassidy","year":"2012","journal-title":"Genet Med"},{"key":"2023061601034999600_dgad015-B2","first-page":"1","volume-title":"GeneReviews((R))","author":"Driscoll","year":"1993"},{"issue":"4","key":"2023061601034999600_dgad015-B3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1573396315666190716120925","article-title":"Prader-Willi syndrome\u2014clinical genetics, diagnosis and treatment approaches: an update","volume":"15","author":"Butler","year":"2019","journal-title":"Curr Pediatr Rev"},{"issue":"6","key":"2023061601034999600_dgad015-B4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3945\/an.117.016253","article-title":"Energy metabolism profile in individuals with Prader-Willi syndrome and implications for clinical management: a systematic review","volume":"8","author":"Alsaif","year":"2017","journal-title":"Adv Nutr"},{"issue":"5","key":"2023061601034999600_dgad015-B5","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ajmg.a.33951","article-title":"Nutritional phases in Prader-Willi syndrome","volume":"155A","author":"Miller","year":"2011","journal-title":"Am J Med Genet A"},{"issue":"5","key":"2023061601034999600_dgad015-B6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ajmg.a.31507","article-title":"Energy expenditure and physical activity in Prader-Willi syndrome: comparison with obese subjects","volume":"143A","author":"Butler","year":"2007","journal-title":"Am J Med Genet A"},{"issue":"1","key":"2023061601034999600_dgad015-B7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s11689-021-09373-2","article-title":"Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the international PWS clinical trial consortium","volume":"13","author":"Schwartz","year":"2021","journal-title":"J Neurodev Disord"},{"issue":"9","key":"2023061601034999600_dgad015-B8","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jaac.2020.01.006","article-title":"Systematic review and meta-analysis: mental health in children with neurogenetic disorders associated with intellectual disability","volume":"59","author":"Glasson","year":"2020","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"2023061601034999600_dgad015-B9","doi-asserted-by":"crossref","first-page":"e0194655","DOI":"10.1371\/journal.pone.0194655","article-title":"High levels of caregiver burden in Prader-Willi syndrome","volume":"13","author":"Kayadjanian","year":"2018","journal-title":"PLoS One"},{"issue":"7","key":"2023061601034999600_dgad015-B10","doi-asserted-by":"crossref","first-page":"e12994","DOI":"10.1111\/jne.12994","article-title":"Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome","volume":"33","author":"Correa-da-Silva","year":"2021","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"2023061601034999600_dgad015-B11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1172\/JCI88648","article-title":"Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome","volume":"127","author":"Burnett","year":"2017","journal-title":"J Clin Invest"},{"issue":"S423","key":"2023061601034999600_dgad015-B12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1651-2227.1997.tb18369.x","article-title":"Prader-Willi syndrome and the hypothalamus","volume":"86","author":"Swaab","year":"1997","journal-title":"Acta Paediatr Suppl"},{"issue":"24","key":"2023061601034999600_dgad015-B13","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1093\/hmg\/ddq424","article-title":"A single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene","volume":"19","author":"Schaller","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2023061601034999600_dgad015-B14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biopsych.2014.11.010","article-title":"An early postnatal oxytocin treatment prevents social and learning deficits in adult mice deficient for Magel2, a gene involved in Prader-Willi syndrome and autism","volume":"78","author":"Meziane","year":"2015","journal-title":"Biol Psychiatry"},{"issue":"3","key":"2023061601034999600_dgad015-B15","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1152\/physrev.00031.2017","article-title":"The oxytocin receptor: from intracellular signaling to behavior","volume":"98","author":"Jurek","year":"2018","journal-title":"Physiol Rev"},{"issue":"18","key":"2023061601034999600_dgad015-B16","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1093\/hmg\/dds228","article-title":"The imprinted NPAP1\/C15orf2 gene in the Prader-Willi syndrome region encodes a nuclear pore complex associated protein","volume":"21","author":"Neumann","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"12","key":"2023061601034999600_dgad015-B17","doi-asserted-by":"crossref","first-page":"e98333","DOI":"10.1172\/jci.insight.98333","article-title":"Intranasal carbetocin reduces hyperphagia in individuals with Prader-Willi syndrome","volume":"3","author":"Dykens","year":"2018","journal-title":"JCI Insight"},{"issue":"12","key":"2023061601034999600_dgad015-B18","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/dom.13021","article-title":"Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: a randomized, double-blind, placebo-controlled trial","volume":"19","author":"McCandless","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"2023061601034999600_dgad015-B19","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00004583-199706000-00023","article-title":"Children's Yale-Brown obsessive compulsive scale: reliability and validity","volume":"36","author":"Scahill","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"2023061601034999600_dgad015-B20","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"issue":"4","key":"2023061601034999600_dgad015-B21","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/biomet\/75.4.800","article-title":"A sharper Bonferroni procedure for multiple tests of significance","volume":"75","author":"Hochberg","year":"1988","journal-title":"Biometrika"},{"issue":"4","key":"2023061601034999600_dgad015-B22","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/biomet\/asm067","article-title":"Hochberg's step-up method: cutting corners off Holm's step-down method","volume":"94","author":"Huang","year":"2007","journal-title":"Biometrika"},{"issue":"B","key":"2023061601034999600_dgad015-B23","first-page":"134","article-title":"Longitudinal data analysis of continuous and discrete responses for pre-post designs","volume":"62","author":"Liang","year":"2000","journal-title":"Sankhy\u0101: Indian J Stat Ser B"},{"issue":"20","key":"2023061601034999600_dgad015-B24","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1002\/sim.3639","article-title":"Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials?","volume":"28","author":"Liu","year":"2009","journal-title":"Stat Med"},{"issue":"12","key":"2023061601034999600_dgad015-B25","doi-asserted-by":"crossref","first-page":"e013096","DOI":"10.1136\/bmjopen-2016-013096","article-title":"To condition or not condition? Analysing \u2018change\u2019 in longitudinal randomised controlled trials","volume":"6","author":"Coffman","year":"2016","journal-title":"BMJ Open"},{"issue":"1","key":"2023061601034999600_dgad015-B26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0079-6123(02)39024-1","article-title":"Cardiovascular effects of oxytocin","volume":"139","author":"Petersson","year":"2002","journal-title":"Prog Brain Res"},{"issue":"9","key":"2023061601034999600_dgad015-B27","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/ajmg.a.36653","article-title":"A double-blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome","volume":"164A","author":"Einfeld","year":"2014","journal-title":"Am J Med Genet A"},{"issue":"6","key":"2023061601034999600_dgad015-B28","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/cen.13169","article-title":"Promising effects of oxytocin on social and food-related behaviour in young children with Prader-Willi syndrome: a randomized, double-blind, controlled crossover trial","volume":"85","author":"Kuppens","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2023061601034999600_dgad015-B29","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ajmg.a.38160","article-title":"Oxytocin treatment in children with Prader-Willi syndrome: a double-blind, placebo-controlled, crossover study","volume":"173","author":"Miller","year":"2017","journal-title":"Am J Med Genet A"},{"issue":"2","key":"2023061601034999600_dgad015-B30","doi-asserted-by":"crossref","first-page":"e20162976","DOI":"10.1542\/peds.2016-2976","article-title":"The use of oxytocin to improve feeding and social skills in infants with Prader-Willi syndrome","volume":"139","author":"Tauber","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"2023061601034999600_dgad015-B31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1172-6-47","article-title":"Oxytocin may be useful to increase trust in others and decrease disruptive behaviours in patients with Prader-Willi syndrome: a randomised placebo-controlled trial in 24 patients","volume":"6","author":"Tauber","year":"2011","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"2023061601034999600_dgad015-B32","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.npp.1300360","article-title":"Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice","volume":"29","author":"Bielsky","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"2023061601034999600_dgad015-B33","doi-asserted-by":"crossref","first-page":"e0248739","DOI":"10.1371\/journal.pone.0248739","article-title":"Characteristics and relationship between hyperphagia, anxiety, behavioral challenges and caregiver burden in Prader-Willi syndrome","volume":"16","author":"Kayadjanian","year":"2021","journal-title":"PLoS One"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad015\/49627945\/dgad015.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/7\/1696\/50604815\/dgad015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/7\/1696\/50604815\/dgad015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T02:05:45Z","timestamp":1686881145000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/7\/1696\/6986298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,1,12]]},"published-print":{"date-parts":[[2023,6,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad015","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7]]},"published":{"date-parts":[[2023,1,12]]}}}